Flexible Microneedle Platform for Synergistic Chemo/Photothermal Ferroptosis Therapy via P-Glycoprotein Inhibition in Breast Cancer
ACS Applied Materials & Interfaces · 30.07.2025 · 17 (30) · 42807-42823
DOI: 10.1021/acsami.5c09308 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 17.07.2025. Verfasst von Zejun Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, PR China. Hauptthemen laut MEDLINE: Ferroptosis, Breast Neoplasms, Doxorubicin, Photothermal Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Combining photothermal therapy (PTT) with chemotherapy shows promise for cancer treatment, but its efficacy is limited by heat shock protein (HSP)-induced thermoresistance and P-glycoprotein (P-gp)-mediated drug efflux. To overcome these challenges, we developed a tumor microenvironment-responsive microneedle platform for synergistic chemotherapy, PTT, and ferroptosis in breast cancer. The system employs Fe3+-coordinated dihydromyricetin (DMY) nanocarriers encapsulating doxorubicin (DMFD NPs) integrated into a flexible polyvinylpyrrolidone (PVP) microneedle patch. The patch adheres tightly to tumors, enabling the rapid delivery and targeted release of DMFD NPs under laser irradiation and acidic conditions. Released Fe3+/Fe2+ ions generate reactive oxygen species (ROS) via Fenton reactions, synergizing with PTT to induce ferroptosis. DMY concurrently inhibits HSP and P-gp, enhancing photothermal-chemotherapy efficacy. In vivo, this approach achieved 92% tumor inhibition, demonstrating its potential to address the limitations of conventional PTT and chemotherapy through localized multifunctional action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, PR China.
- Polymer Materials Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria 21934,…
- State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Enginee…
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, P.R. China.
ORCID-Profile: Xiao Kun Ouyang, Lin Mei
Förderung
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Lin, Z., Ling, J., Omer, A. M., Ouyang, X. K., Mei, L., & Wang, N. (2025). Flexible Microneedle Platform for Synergistic Chemo/Photothermal Ferroptosis Therapy via P-Glycoprotein Inhibition in Breast Cancer. ACS Applied Materials & Interfaces, 17(30), 42807-42823. https://doi.org/10.1021/acsami.5c09308
Vancouver
Lin Z, Ling J, Omer AM, Ouyang XK, Mei L, Wang N. Flexible Microneedle Platform for Synergistic Chemo/Photothermal Ferroptosis Therapy via P-Glycoprotein Inhibition in Breast Cancer. ACS Applied Materials & Interfaces. 2025;17(30):42807-42823. doi:10.1021/acsami.5c09308
BibTeX
@article{Lin2025,
author = {Lin, Zejun and Ling, Junhong and Omer, A M and Ouyang, Xiao Kun and Mei, Lin and Wang, Nan},
title = {Flexible Microneedle Platform for Synergistic Chemo/Photothermal Ferroptosis Therapy via P-Glycoprotein Inhibition in Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {30},
pages = {42807--42823},
doi = {10.1021/acsami.5c09308}
}
EUVIMED